Brain Cancer Information Center
Knowledge is power. Are you facing a new diagnosis, recurrence, living with metastatic disease, or supporting a loved one through their cancer journey? The Cancer Connect Brain Cancer Information Center has current, evidence-based information for you. Get the facts about brain cancer early detection, treatment, and survivorship, and stay up to date with ongoing brain cancer research that could impact your treatment decisions through our daily cancer news.
You are not alone—The CancerConnect Brain Cancer Community is the leading Social Media Application for Brain Cancer patients and caregivers seeking information, inspiration, and support in the wake of a cancer diagnosis. With over 50,000 members the network offers patients and caregivers a thriving community to support the many ongoing needs from diagnosis to survivorship. Login or register here.
The United States Food and Drug Administration (FDA) has granted “breakthrough... Avastin®/Camptosar® Improves Outcomes Compared with Temodar® in Glioblastoma
The treatment combination consisting of Avastin (bevacizumab) plus Camptosar (irinotecan)... Data Safety and Monitoring Board Recommends Celldex’s Phase 3 Study of RINTEGA® in Newly Diagnosed Glioblastoma Be Discontinued
Celldex Therapeutics, Inc. announced today that the independent Data Safety and Monitoring...
Cancer and its treatment can come with a variety of complications, some more serious... Advanced Directives
Living Wills Every competent adult has, in most cases, the freedom to accept or refuse... Caregivers
What is Caregiving and Who are Caregivers? Caregivers are individuals who provide...
There's not a typical brain tumor survivor." The reality is, "brain tumors can affect anyone—both sexes, all races and ethnicities, and any age." National Brain Tumor Foundation
“This is an exciting time in brain tumor research,” says Harriet Patterson, MPH.... Moving Bodies, Changing Lives
Moving On Aerobics helps women regain joy of movement and physical fitness after...
Brain Cancer Clinical Trials
COGACNS0332 – A groupwide phase III study- Efficacy of Carboplatin Administered Concomitantly with Radiation and Isotretinoin as a Pro-Apoptotic Agent in Other Than average risk medulloblastoma/PNET patients
COGACNS0621 – Cilengitide in Recurrent or Progressive and Refractory Childhood High-Grade Glioma
COGACNS0334 – A Phase III Randomized Trial for the Treatment of Newly Diagnosed Supratentorial PNET and High Risk Medulloblastoma in Children less than 36 months Old With Intensive Induction Chemotherapy with Methotrexate Followed by Consolidation with Stem Cell Rescue vs. the Same Therapy Without Methotrexate